Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Unicycive Therapeutics (UNCY – Research Report) today and set a price ...
Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback